ACHV
Price
$4.58
Change
-$0.14 (-2.97%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
251.8M
119 days until earnings call
Intraday BUY SELL Signals
SIGY
Price
Loading...
Change
-$0.00 (-0.00%)
Updated
Loading...
Capitalization
3.21M
Intraday BUY SELL Signals
Interact to see
Advertisement

ACHV vs SIGY

Header iconACHV vs SIGY Comparison
Open Charts ACHV vs SIGYBanner chart's image
Achieve Life Sciences
Price$4.58
Change-$0.14 (-2.97%)
Volume$6.02K
Capitalization251.8M
Sigyn Therapeutics
PriceLoading...
Change-$0.00 (-0.00%)
Volume$1.1K
Capitalization3.21M
ACHV vs SIGY Comparison Chart in %
ACHV
Daily Signal:
Gain/Loss:
SIGY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ACHV vs. SIGY commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACHV is a Hold and SIGY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (ACHV: $4.72 vs. SIGY: $2.00)
Brand notoriety: ACHV and SIGY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACHV: 37% vs. SIGY: 70%
Market capitalization -- ACHV: $251.8M vs. SIGY: $3.21M
ACHV [@Biotechnology] is valued at $251.8M. SIGY’s [@Biotechnology] market capitalization is $3.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACHV’s FA Score shows that 0 FA rating(s) are green whileSIGY’s FA Score has 0 green FA rating(s).

  • ACHV’s FA Score: 0 green, 5 red.
  • SIGY’s FA Score: 0 green, 5 red.
According to our system of comparison, ACHV is a better buy in the long-term than SIGY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACHV’s TA Score shows that 5 TA indicator(s) are bullish while SIGY’s TA Score has 3 bullish TA indicator(s).

  • ACHV’s TA Score: 5 bullish, 4 bearish.
  • SIGY’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ACHV is a better buy in the short-term than SIGY.

Price Growth

ACHV (@Biotechnology) experienced а -4.26% price change this week, while SIGY (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

ACHV is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACHV($252M) has a higher market cap than SIGY($3.21M). ACHV YTD gains are higher at: 34.091 vs. SIGY (-36.508). SIGY has higher annual earnings (EBITDA): -2.39M vs. ACHV (-49.25M). ACHV has more cash in the bank: 55.4M vs. SIGY (12.9K). SIGY has less debt than ACHV: SIGY (2.51M) vs ACHV (9.96M). ACHV (0) and SIGY (0) have equivalent revenues.
ACHVSIGYACHV / SIGY
Capitalization252M3.21M7,848%
EBITDA-49.25M-2.39M2,060%
Gain YTD34.091-36.508-93%
P/E RatioN/AN/A-
Revenue00-
Total Cash55.4M12.9K429,457%
Total Debt9.96M2.51M396%
FUNDAMENTALS RATINGS
ACHV vs SIGY: Fundamental Ratings
ACHV
SIGY
OUTLOOK RATING
1..100
8615
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
78
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
3688
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACHV's Valuation (53) in the Biotechnology industry is in the same range as SIGY (78) in the null industry. This means that ACHV’s stock grew similarly to SIGY’s over the last 12 months.

ACHV's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as SIGY (100) in the null industry. This means that ACHV’s stock grew similarly to SIGY’s over the last 12 months.

ACHV's SMR Rating (99) in the Biotechnology industry is in the same range as SIGY (100) in the null industry. This means that ACHV’s stock grew similarly to SIGY’s over the last 12 months.

ACHV's Price Growth Rating (36) in the Biotechnology industry is somewhat better than the same rating for SIGY (88) in the null industry. This means that ACHV’s stock grew somewhat faster than SIGY’s over the last 12 months.

SIGY's P/E Growth Rating (98) in the null industry is in the same range as ACHV (100) in the Biotechnology industry. This means that SIGY’s stock grew similarly to ACHV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACHVSIGY
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
61%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
63%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
66%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
54%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 24 days ago
80%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
ACHV
Daily Signal:
Gain/Loss:
SIGY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KRO4.840.05
+1.04%
Kronos Worldwide
CVBF18.71-0.01
-0.05%
CVB Financial Corp
FSI8.03-0.13
-1.59%
Flexible Solutions International
LII476.95-10.44
-2.14%
Lennox International
YCBD0.77-0.03
-3.72%
CBDMD Inc

ACHV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACHV has been loosely correlated with ALT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ACHV jumps, then ALT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHV
1D Price
Change %
ACHV100%
-1.05%
ALT - ACHV
46%
Loosely correlated
-1.17%
ATNM - ACHV
36%
Loosely correlated
-0.76%
PLRX - ACHV
36%
Loosely correlated
+7.78%
ARTV - ACHV
33%
Loosely correlated
+10.86%
RANI - ACHV
33%
Poorly correlated
+9.28%
More

SIGY and

Correlation & Price change

A.I.dvisor tells us that SIGY and OTLK have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SIGY and OTLK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SIGY
1D Price
Change %
SIGY100%
N/A
OTLK - SIGY
23%
Poorly correlated
+3.23%
ACHV - SIGY
21%
Poorly correlated
-1.05%
KALA - SIGY
21%
Poorly correlated
-2.55%
CSPHF - SIGY
8%
Poorly correlated
N/A
CPMV - SIGY
6%
Poorly correlated
N/A
More